Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E7 TCR-T cells for HPV-Associated Cancers
NCT05686226Phase 2Recruiting
- Sponsor
- Christian Hinrichs
- Start
- Mar 2023
- Primary completion
- Jan 2027
- Modality
- Gene Editing, Gene Silencing, TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of KITE-439 in HPV-associated cancer, sponsored by Christian Hinrichs. Started Mar 2023; status: recruiting.
02
Drugs
KITE-439
03
Conditions
HPV-associated cancer
Beyond the preview
Go deeper on NCT05686226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05686226.